Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Commercial services symbols : Pfe save search
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.21%
H: 0.11%
C: -1.06%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.9%
H: 2.03%
C: 1.89%
VERU | $1.42 22.41% 18.31% 7M
|
Health Technology
|
| O: -0.53%
H: 2.22%
C: -3.59%
ALT | $6.9 -1.99% -2.03% 3.2M
|
Commercial Services
|
| O: 0.3%
H: 11.41%
C: 9.8%
medical program
Pharmaceutical Contract Manufacturing & Research Services Market to Surpass $275.2 Billion by 2027
Published: 2022-08-25 (Crawled : 19:00) - prnewswire.com
WST | $377.33 -0.01% 0.0% 320K
|
Health Technology
|
| O: -0.06%
H: 0.16%
C: -3.41%
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.58%
H: 0.71%
C: -1.68%
CRL | $227.55 -1.1% 0.0% 710K
|
Commercial Services
|
| O: -0.32%
H: 0.01%
C: -3.92%
research services contract market
Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Gedatolisib, a First-in-Class PI3K/mTOR Inhibitor for Breast Cancer
Published: 2021-04-08 (Crawled : 21:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.14%
H: 0.53%
C: 0.0%
CELC | $16.4 -3.59% -3.72% 200K
|
Commercial Services
|
| O: -1.04%
H: 0.42%
C: 0.42%
cancer breast cancer commercialization license
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.